Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination.
Matsumura
S
S
Department of Microbiology, Sunnybrook Health Science Centre, University of Toronto, Ontario, Canada.
Simor
A E
AE
D000368:Aged; D004318:Doxycycline / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004359:Drug Therapy, Combination / Q000494:pharmacology / Q000627:therapeutic use*; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D016984:Enterococcus faecium / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use; D014640:Vancomycin / Q000494:pharmacology; D014769:Virginiamycin / Q000494:pharmacology / Q000627:therapeutic use
D014769:Virginiamycin; C062940:quinupristin-dalfopristin; D014640:Vancomycin; D004318:Doxycycline; D012293:Rifampin